10 Firms Kick Off Trading Week Soaring

5. Guardant Health Inc. (NASDAQ:GH)

Guardant Health’s (GH) share prices increased by 23.10 percent on Tuesday to finish at $45.13 apiece following news that its Guardant Reveal test for colon cancer has been granted expanded Medicare coverage.

According to Guardant Health (GH), Palmetto GBA, a Medicare administrative contractor, has extended the coverage for the test, allowing for the monitoring of disease recurrence in patients with colorectal cancer (CRC), who have undergone curative intent therapy.

Guardant Health (GH) said the development marked an expansion from the previous Medicare coverage, as its previous coverage was only limited to CRC testing in the early post-surgical setting.

With the new coverage, Guardant Health (GH) can now offer more comprehensive monitoring for CRC patients throughout their treatment journey.